🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this article, associate editor Brian Gazaille speaks with Hong Jiang (cofounder and chief operating officer of AegisLifeInc) to learn more about plasmid-DNA #vaccines. #emergingtherapeutics Read the interview now: ow.ly/9uOf50DuQsy

Big day! 1st of 72 recruits injected marking Phase I trial start of Aegis & entospharma COVID-19 DNA vaccine, Covigenix VAX-001, conducted by @VACCres. DNA vaccines deliver info to our cells to make viral protein to trigger immunity. @IWKHealth #COVID19Vaccine

We're excited that the Phase 1/2 trials have begun with the Entos COVID-19 DNA vaccine, Covigenix VAX-001! #COVID19 #Covid19Vaccines businesswire.com/news/home/2021…

Phase 1/2 trials for entospharma & AegisLifeInc COVID-19 DNA vaccine Covigenix VAX-001 began April 15 after successful primate immunological studies conducted by Virscio @ St. Kitts Biomedical Research Foundation. #vaccinedevelopment sknvibes.com/news/newsdetai…

Entos’ COVID-19 vaccine Phase trial met 1st milestone-thank you Halifax! CCfV is now enrolling Halifax area adults to complete the trial. Interested? Learn more at bit.ly/trialvolunteer #COVID19Vaccines BioAlberta Dalhousie University @VACCres Global Public Affairs UAlberta Research & Innovation

Interested in volunteering? Please contact IWK! Details in CBC news below. #COVID19 Global Public Affairs Dalhousie University UAlberta Research & Innovation cbc.ca/news/canada/no…

#Halifax area adults; want to take part in a made-in-Canada, Dal_Micro&Imm linked, #COVID19NS vaccine study? Seeking volunteers now! Go to @VACCres at bit.ly/2RMtJBj or see below. #CovidVaccine Research Nova Scotia Account is no longer active. Follow @NSHealthHub Global Public Affairs Coldwell Banker Commercial Atlantic UAlberta Research & Innovation

Attending the Alliance for Regenerative Medicine (ARM) Cell and Gene Meeting on the MESA? Connect with us to learn about how our nucleic acid delivery platform Fusogenix PLV can accelerate clinical R&D, and manufacture of vaccines and therapeutics for infectious diseases. #CGMESA21

CEO John Lewis says Entos hoped to develop single vaccine that protects against all coronaviruses by years' end. Entos & 20+ groups racing to develop all-in-one vaccines face difficulties. Read @ businessinsider.com/scientist-boos… via @businessinsider Global Public Affairs BioAlberta UAlberta Research & Innovation

Celebrating another #NewMemberMonday! 💉AegisLifeInc helps prevent infectious diseases through Fusogenix technology + next-gen vaccines & tx 🧽Redefining Clean is innovating cleaning technologies powered by science 🧴ロート製薬 広報PRチーム develops a wide range of health products

Our Aegis Life family wishes you a wonderful and healthy holiday season and all the best in 2022! #holidayseason2021 #HappyHolidays #Happy2022

Validation of Covid-19 mRNA vaccines was a 2021 highlight, but specific storage/transport complicated roll-outs. DNA vaccine tech like Fusogenix PLVs could be an improvement on current vaccines. COO Hong Jiang spoke to WorldPharma. Read bit.ly/3AAccyB #COVID19vaccines

Today, BioAlberta and @BioTalentCanada announced the PetriDish BioAlberta job board – giving bio-economy employers a tried and tested platform to attract highly-skilled talent. Members of BioAlberta will receive additional benefits. Visit bioalberta.com/alberta-petri-… to learn more

Today is #WorldCancerDay, and we want to recognize all who are affected by cancer, as well as researchers who work tirelessly to end the global impact of the disease. #CancerResearch #CloseTheCareGap

Today is #InternationalDayofWomenandGirlsinScience and we want to recognize these incredible #WomenInStem at Aegis Life, entospharma, Oisin, OncoSenX. Thanks for all that you do! #WomenInSTEM

It's #EmployeeAppreciationDay! A special #ThankYou to our team and our sister companies entospharma, Oisin, and OncoSenX. We greatly appreciate your dedication to developing Fusogenix PLV nucleic acid vaccines & therapies for infectious diseases. #PLV

Check out this awesome read from BioPharm Intl about the development of #nucleic acid-based #therapeutics. For more insight, click the link below! bit.ly/37fS1ev #plv

Thrilled to announce the launch of our new shared #SanDiego site with entospharma! Home to pivotal research in Fusogenix PLV #GeneticMedicine and #vaccinedevelopment. #plv #entos_sandiego #entosusa businesswire.com/news/home/2022… BioAlberta BIOTECanada

Entos Expands R&D Operations into the US - businesswire.com/news/home/2022…

Entos Pharma Moves into Torrey Pines Life Science Campus | San Diego Business Journal - goo.gl/alerts/uiriE #GoogleAlerts